Contribution: Industrial Research Assistance Program – Contributions to Firms
Nanostics Inc.
$500,000.00
Validation of Stability and Accuracy of Antibodies and AI/ML Algorithm for Prostate Diagnostic Test
FY 2021-22 · 2021-11-01
Summary
The Nanostics project involves validation of novel biomarkers for ClarityDx Prostate, a prostate cancer diagnostic test that significantly improves the standard of care for prostate cancer from a standard blood draw.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Edmonton|Edmonton, Alberta, Canada
Recipient Type
For-profit organization
Business Number
707942124
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-11-01 | 2021-22 | $335,000.00 |
| 1 | 2021-11-01 | 2021-22 | $500,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by -30 days. The total amended value is 165,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de -30 jours. La valeur totale des modifications est de 165 000 dollars.
Agreement End Date
2023-03-31
Agreement Number
981503
Agreement Start Date
2021-11-01
Agreement Title
Validation of Stability and Accuracy of Antibodies and AI/ML Algorithm for Prostate Diagnostic Test
Agreement Title (French)
Validation de la stabilité et de la précision des anticorps et de l'algorithme IA/AM pour le test de diagnostic de la prostate
Agreement Type
Contribution
Agreement Value
$500,000.00
Amendment Date
2022-08-18
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The Nanostics project involves validation of novel biomarkers for ClarityDx Prostate, a prostate cancer diagnostic test that significantly improves the standard of care for prostate cancer from a standard blood draw.
Description (French)
Le projet Nanostics comprend la validation de nouveaux biomarqueurs pour ClarityDx Prostate, un test de diagnostic du cancer de la prostate, qui améliore considérablement la norme de soins pour le cancer de la prostate à partir d'une prise de sang standard.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Centre
Federal Riding (French)
Edmonton-Centre
Federal Riding Number
48014
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
707942124
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
Nanostics Inc.
Recipient Postal Code
T5J 4P6
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2021-2022-Q3-981503
